Putnam Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$300K Buy
2023
Q1
$329K Sell
2022
Q4
$472K Sell
2022
Q3
$518K Sell
2022
Q2
$443K Sell
2022
Q1
$690K Sell
2021
Q4
$629K Buy
2016
Q1
Sell
2015
Q4
$2.06M Hold
2015
Q3
$2.27M Hold
2015
Q2
$2.97M Sell
2015
Q1
$1.82M Buy